- Home
- ENX vs VIGL Comparison
ENX vs VIGL Comparison
Compare ENX & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- VIGL
- Stock Information
- Founded
- ENX 2002
- VIGL 2020
- Country
- ENX United States
- VIGL United States
- Employees
- ENX N/A
- VIGL N/A
- Industry
- ENX Finance/Investors Services
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- ENX Finance
- VIGL Health Care
- Exchange
- ENX Nasdaq
- VIGL Nasdaq
- Market Cap
- ENX 165.4M
- VIGL 134.9M
- IPO Year
- ENX N/A
- VIGL 2022
- Fundamental
- Price
- ENX $9.26
- VIGL $7.99
- Analyst Decision
- ENX
- VIGL Buy
- Analyst Count
- ENX 0
- VIGL 7
- Target Price
- ENX N/A
- VIGL $8.00
- AVG Volume (30 Days)
- ENX 25.4K
- VIGL 1.6M
- Earning Date
- ENX 01-01-0001
- VIGL 08-12-2025
- Dividend Yield
- ENX 3.94%
- VIGL N/A
- EPS Growth
- ENX N/A
- VIGL N/A
- EPS
- ENX 0.16
- VIGL N/A
- Revenue
- ENX N/A
- VIGL N/A
- Revenue This Year
- ENX N/A
- VIGL N/A
- Revenue Next Year
- ENX N/A
- VIGL N/A
- P/E Ratio
- ENX $61.00
- VIGL N/A
- Revenue Growth
- ENX N/A
- VIGL N/A
- 52 Week Low
- ENX $7.84
- VIGL $1.31
- 52 Week High
- ENX $10.07
- VIGL $8.00
- Technical
- Relative Strength Index (RSI)
- ENX 57.92
- VIGL 88.87
- Support Level
- ENX $9.25
- VIGL $7.86
- Resistance Level
- ENX $9.35
- VIGL $7.96
- Average True Range (ATR)
- ENX 0.08
- VIGL 0.02
- MACD
- ENX 0.02
- VIGL -0.18
- Stochastic Oscillator
- ENX 80.00
- VIGL 93.33
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.